跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TEGSEDI
Authorized
STANDARD
TEGSEDI
Akcea Therapeutics, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
092492ef9d107b86
Company
Akcea Therapeutics, Inc.
Type
Standard
Approval Details
Approval Id
092492ef9d107b86
Drug Approval Canada Name
TEGSEDI
Product Name
TEGSEDI
Status
Cancelled Post Market
Status Date
2024-10-24
Original Market Date
2019-01-07
Din
02481383
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
92:18.00
Atc Original
N07XX15 INOTERSEN
Atc Name
n 07 xx 15
Aig Number
0160712001
Company Name
Akcea Therapeutics, Inc.
Company Address
2850 Gazelle Court, Carlsbad, California, United States, 92010
Company Detail Path
/organization/akcea-therapeutics-inc
Company Information
Pharmaceutical Company Name
Akcea Therapeutics, Inc.
Country Name
United States
Province Name
California
City Name
carlsbad,california,country_us
Address
2850 Gazelle Ct
Website
http://akceatx.com
Active Ingredients
INOTERSEN (INOTERSEN SODIUM)
284 MG / 1.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
092492ef9d107b86
Type
Standard
Back to Health Canada Approvals
TEGSEDI - Health Canada Drug Approval Details